A. Van Peer

1.9k total citations
37 papers, 1.4k citations indexed

About

A. Van Peer is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Infectious Diseases. According to data from OpenAlex, A. Van Peer has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pediatrics, Perinatology and Child Health, 7 papers in Pharmacology and 6 papers in Infectious Diseases. Recurrent topics in A. Van Peer's work include Antifungal resistance and susceptibility (6 papers), Anesthesia and Sedative Agents (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). A. Van Peer is often cited by papers focused on Antifungal resistance and susceptibility (6 papers), Anesthesia and Sedative Agents (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). A. Van Peer collaborates with scholars based in Belgium, Netherlands and United States. A. Van Peer's co-authors include R. Woestenborghs, J. Heykants, W. Meuldermans, Karel Lavrijsen, G. Cauwenbergh, Vera Van de Velde, J. Van Cutsem, P. Van Rooy, Roberto Gasparini and Robert Woestenborghs and has published in prestigious journals such as Biological Psychiatry, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

A. Van Peer

36 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Van Peer Belgium 18 456 378 212 209 194 37 1.4k
J Heykants Belgium 20 215 0.5× 169 0.4× 249 1.2× 229 1.1× 153 0.8× 37 1.3k
J. Heykants Belgium 22 650 1.4× 227 0.6× 310 1.5× 263 1.3× 249 1.3× 59 2.2k
Gary E. Pakes United States 21 784 1.7× 300 0.8× 111 0.5× 236 1.1× 156 0.8× 49 2.0k
David R. Luke United States 25 346 0.8× 292 0.8× 105 0.5× 293 1.4× 198 1.0× 87 1.9k
Robert A. Blum United States 24 396 0.9× 281 0.7× 252 1.2× 470 2.2× 284 1.5× 83 2.4k
Elaine Radwanski United States 21 369 0.8× 421 1.1× 160 0.8× 299 1.4× 304 1.6× 62 1.8k
Karel Lavrijsen Belgium 15 307 0.7× 226 0.6× 438 2.1× 192 0.9× 124 0.6× 27 1.2k
R. Woestenborghs Belgium 18 562 1.2× 562 1.5× 190 0.9× 170 0.8× 161 0.8× 26 1.7k
H Laufen Germany 22 365 0.8× 470 1.2× 176 0.8× 325 1.6× 104 0.5× 76 1.5k
W. Meuldermans Belgium 30 344 0.8× 268 0.7× 871 4.1× 432 2.1× 343 1.8× 70 2.8k

Countries citing papers authored by A. Van Peer

Since Specialization
Citations

This map shows the geographic impact of A. Van Peer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Van Peer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Van Peer more than expected).

Fields of papers citing papers by A. Van Peer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Van Peer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Van Peer. The network helps show where A. Van Peer may publish in the future.

Co-authorship network of co-authors of A. Van Peer

This figure shows the co-authorship network connecting the top 25 collaborators of A. Van Peer. A scholar is included among the top collaborators of A. Van Peer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Van Peer. A. Van Peer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peer, A. Van, et al.. (2025). Pharmacokinetic Evaluation of Niacin and Pterostilbene in Single and Multi-Doses in Healthy Subjects. Jordan Journal of Pharmaceutical Sciences. 18(1). 217–229.
2.
Mouton, Johan W., et al.. (2006). Pharmacokinetics of Itraconazole and Hydroxyitraconazole in Healthy Subjects after Single and Multiple Doses of a Novel Formulation. Antimicrobial Agents and Chemotherapy. 50(12). 4096–4102. 60 indexed citations
3.
Snoeck, Eric, Philippe Jacqmin, A. Van Peer, et al.. (1997). Population analysis of the non linear red blood cell partitioning and the concentration‐effect relationship of draflazine following various infusion rates. British Journal of Clinical Pharmacology. 43(6). 603–612. 5 indexed citations
4.
Snoeck, Eric, Philippe Jacqmin, R. Lins, et al.. (1997). Population analysis of the non-linear red blood cell partitioning of draflazine following various infusion durations. European Journal of Clinical Pharmacology. 53(1). 57–63. 2 indexed citations
5.
Snoeck, Eric, Philippe Jacqmin, A. Van Peer, et al.. (1996). The implications of non‐linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine. British Journal of Clinical Pharmacology. 42(5). 605–613. 9 indexed citations
6.
Peer, A. Van, Eric Snoeck, Minxue Huang, & J Heykants. (1993). Pharmacokinetic-pharmacodynamic relationships in Phase I/Phase II of drug development. European Journal of Drug Metabolism and Pharmacokinetics. 18(1). 49–59. 14 indexed citations
7.
Lehmann, K. A., et al.. (1993). Pharmacokinetics of sufentanil in general surgical patients under different conditions of anaesthesia. Acta Anaesthesiologica Scandinavica. 37(2). 176–180. 15 indexed citations
8.
Peer, A. Van, Eric Snoeck, Robert Woestenborghs, et al.. (1991). Clinical Pharmacokinetics of Nebivolol. Clinical Drug Investigation. 3(S1). 25–30. 37 indexed citations
9.
Coster, R. De, Walter Wouters, C R Bowden, et al.. (1990). New non-steroidal aromatase inhibitors: Focus on R76713. The Journal of Steroid Biochemistry and Molecular Biology. 37(3). 335–341. 49 indexed citations
10.
Marlow, Neil, A M Weindling, A. Van Peer, & J. Heykants. (1990). Alfentanil pharmacokinetics in preterm infants.. Archives of Disease in Childhood. 65(4 Spec No). 349–351. 38 indexed citations
11.
Hedner, Thomas, Jan Hedner, Minxue Huang, et al.. (1990). Comparative bioavailability of a cisapride suppository and tablet formulation in healthy volunteers. European Journal of Clinical Pharmacology. 38(6). 629–631. 14 indexed citations
12.
Peer, A. Van, et al.. (1990). Ketanserin pharmacokinetics in patients with renal failure.. British Journal of Clinical Pharmacology. 29(6). 715–723. 6 indexed citations
13.
Peer, A. Van, et al.. (1989). The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects. European Journal of Clinical Pharmacology. 36(4). 423–426. 140 indexed citations
14.
Peer, A. Van, Roberto Gasparini, Robert Woestenborghs, et al.. (1989). PHARMACOKINETICS OF ALFENTANIL DURING AND AFTER A FIXED RATE INFUSION. British Journal of Anaesthesia. 62(6). 610–615. 12 indexed citations
15.
Helmers, J. H. J. H., H Noorduin, A. Van Peer, L. van Leeuwen, & W. W. A. Zuurmond. (1989). Comparison of intravenous and intranasal sufentanil absorption and sedation. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 36(5). 494–497. 64 indexed citations
16.
Peer, A. Van, et al.. (1989). Cisapride-Cimetidine Interaction. Therapeutic Drug Monitoring. 11(4). 411–414. 1 indexed citations
17.
Lehmann, K. A., et al.. (1988). PHARMACOKINETICS OF DROPERIDOL IN SURGICAL PATIENTS UNDER DIFFERENT CONDITIONS OF ANAESTHESIA. British Journal of Anaesthesia. 61(3). 297–301. 19 indexed citations
18.
Boelaert, Johan R., E Matthys, R Daneels, et al.. (1988). Itraconazole pharmacokinetics in patients with renal dysfunction. Antimicrobial Agents and Chemotherapy. 32(10). 1595–1597. 56 indexed citations
19.
Heykants, J., et al.. (1986). Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administration. European Journal of Clinical Pharmacology. 31(3). 343–350. 34 indexed citations
20.
Peer, A. Van, et al.. (1985). The use and limitations of deuterated lorcainide in metabolism and pharmacokinetic studies. Journal of Mass Spectrometry. 12(1). 38–42. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Heykants Breakdown of academic impact, for papers by J. Heykants Breakdown of academic impact, for papers by Gary E. Pakes Breakdown of academic impact, for papers by David R. Luke Breakdown of academic impact, for papers by Robert A. Blum Breakdown of academic impact, for papers by Elaine Radwanski Breakdown of academic impact, for papers by Karel Lavrijsen Breakdown of academic impact, for papers by R. Woestenborghs Breakdown of academic impact, for papers by H Laufen Breakdown of academic impact, for papers by W. Meuldermans
Rankless by CCL
2026